| Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| private:encellin | 7973731 | Apr 21st, 2024 12:00AM | Encellin | 888 | 8.00 | Open | Apr 21st, 2024 05:58AM | Apr 21st, 2024 05:58AM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 20th, 2024 12:00AM | Encellin | 888 | 8.00 | Open | Apr 20th, 2024 04:57AM | Apr 20th, 2024 08:14PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 19th, 2024 12:00AM | Encellin | 887 | 8.00 | Open | Apr 19th, 2024 07:21AM | Apr 19th, 2024 07:21AM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 18th, 2024 12:00AM | Encellin | 887 | 8.00 | Open | Apr 18th, 2024 06:02AM | Apr 18th, 2024 09:34PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 17th, 2024 12:00AM | Encellin | 886 | 8.00 | Open | Apr 17th, 2024 07:21AM | Apr 17th, 2024 06:02PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 16th, 2024 12:00AM | Encellin | 887 | 8.00 | Open | Apr 16th, 2024 04:46AM | Apr 16th, 2024 02:20PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 15th, 2024 12:00AM | Encellin | 887 | 8.00 | Open | Apr 15th, 2024 07:41AM | Apr 15th, 2024 08:00PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 14th, 2024 12:00AM | Encellin | 886 | 8.00 | Open | Apr 14th, 2024 03:38AM | Apr 14th, 2024 03:38AM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 13th, 2024 12:00AM | Encellin | 886 | 8.00 | Open | Apr 13th, 2024 02:34AM | Apr 13th, 2024 02:43PM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin | ||||||||
| private:encellin | 7973731 | Apr 12th, 2024 12:00AM | Encellin | 886 | 8.00 | Open | Apr 12th, 2024 02:45AM | Apr 12th, 2024 11:48AM | Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases. | Open | Open | Mountain View | US | Encellin |